Fulltext

Factors associated with suboptimal adherence to antiretroviral therapy in Asia

Jiamsakul A 1 , Kumarasamy N 2 , Ditangco R 3 , Li PC 4 , Phanuphak P 5 , Sirisanthana T 6 Show all authors , Sungkanuparph S 7 , Kantipong P 8 , K C Lee C 9 , Mustafa M 10 , Merati T 11 , Kamarulzaman A 12 , Singtoroj T 13 , Law M 14 , TREAT Asia Studies to Evaluate Resistance Monitoring Study (TASER-M)

Affiliations 

  • 1 The Kirby Institute, UNSW Australia, Sydney, Australia; ajiamsakul@kirby.unsw.edu.au
  • 2 YRGCARE Medical Centre, Chennai, India
  • 3 Research Institute for Tropical Medicine, Manila, Philippines
  • 4 Department of Medicine, Queen Elizabeth Hospital, Hong Kong, China
  • 5 Faculty of Medicine, Chulalongkorn University and HIV-NAT/Thai Red Cross AIDS Research Centre, Bangkok, Thailand
  • 6 Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand
  • 7 Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
  • 8 Chiangrai Prachanukroh Hospital, Chiang Rai, Thailand
  • 9 Hospital Sungai Buloh, Sungai Buloh, Malaysia
  • 10 Hospital Raja Perempuan Zainab II, Kota Bharu, Malaysia
  • 11 Udayana University, Sanglah Hospital, Bali, Indonesia
  • 12 University of Malaya Medical Center, Kuala Lumpur, Malaysia
  • 13 TREAT Asia, amfAR - The Foundation for AIDS Research, Bangkok, Thailand
  • 14 The Kirby Institute, UNSW Australia, Sydney, Australia
J Int AIDS Soc, 2014;17:18911.
PMID: 24836775 DOI: 10.7448/IAS.17.1.18911

Abstract

Adherence to antiretroviral therapy (ART) plays an important role in treatment outcomes. It is crucial to identify factors influencing adherence in order to optimize treatment responses. The aim of this study was to assess the rates of, and factors associated with, suboptimal adherence (SubAdh) in the first 24 months of ART in an Asian HIV cohort.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications